Tag Archives: Gouge stitch

    The new policy, I think we will be here many, many companies feel the immediate impact of antimicrobial drugs is now so strict control of our future operations, sales and even the layout of the target market to see how, probably will have some impact. The introduction of the policy background, this topic has been talked about at least three or four years, said the Chinese anti-bacterial medicinal too, and my impression that a lot of data we use antibiotics used to say simply outrageous. So that together, the actual drug resistance (English) also has a lot of problems out.

    Practical point of view has been from the Ministry of Health wants to limit this thing, but also for many years, at least three or four years, in that we can do anything to limit the children these things. Practice has proved that in the end, in fact, this trend has not changed over the past ten years there, first of antibiotics has been China\\ s largest market, growth has been quickly the second, third antibiotic sales which, we are all peers, antibiotic sales behind the trick is simply endless, and the amount actually be the last of our own business is now injured, said antibiotics do it too difficult to do this thing, the trade rumors and even 80% of the rebate can give to the hands of doctors, We do antibiotics pharmaceutical companies are also injured.

    Now we want to change this situation, how? In fact, from the whole, from policy trends, of course, not just that this year, out of the new policy to go along with this idea, in fact, the Ministry of Health has been thought to antibiotics is a three-pronged management, from the variety of restrictions on how, medication specification how to get to the so-called hierarchical management how to implement the program. In fact, so far this year, there are the so-called management approach them. Are limited to the original direction, policy, has been missing is the specific management measures, on one level in the end how do you manage this one thing, he saw the results, of course, many of us, including this time the new medical reform, the entire down there a lot of new things, ideas many, many ways, the policy number, how to perform the last fact missing. Has always been the problem. This time this year, in April this year, I feel the introduction of a policy, you see the direction it actually has not changed, the emphasis is the specific implementation, which in the end how to do a management. Not a few months out in April, August, and we know that a policy out of its adjustment, the actual implementation you see down, the Ministry of Health determined that there is a certain time, in the end how to change it, say within four months of the original policies should be revised, is the level of policy implementation in many parts of the original or not perform, he is willing to change it again.

    Later, under the new policy, said in August down how the implementation of the future, we all like each (in English) do visit, we will feel really slow to implement, because it involves too many things too much. Such as species limits, a bit like our price, this is set, the best execution, we see that city, began to go large hospitals, the top three hospitals in Guangzhou are not started, but in Shanghai, Beijing started. In fact, we see companies in this regard, public relations at the hospital level, which significantly increased, which is now seen. In fact, now that August day out which was the final analysis, the hospital did not begin enforcement of the deadline, the deadline where this figure which we thought, we talking about, when implemented, probably have a while.

    There is power together, we actually see is a general concept of income. Each hospital has a dedicated management committee called the antibiotics, or should they decide to open. Patients in the ICU, where you think, to use a special class of antibiotics, if not in charge of its two expert how should we do, in fact, many issues are still to look at. Interpretation of the policy a little bit, if we do business we are very familiar with antibiotics, a variety of restrictions on the most obvious limitation is the amount required, three hospitals 50 varieties and two hospitals thirty-five kinds of concepts, what is the situation now ? A larger type of the top three hospitals in 99 kinds of antibiotics, two hospitals and some up to more than one hundred kinds now reduced to 35 kinds. And must be done, the President should be held responsible. Varieties do it if I feel it should soon. Norms that are classified, so-called ordinary medication. What types of different situations of antibiotics, use of antibiotics in fact the worst is in front, is one, the direction of policy change now that the management of this class of drugs to be more strict. Such as penicillin, the original was open now and it was open, policy analysis point of view may not be able to misuse of antibiotics for this one thing reversed. Of course there are some very specific things, what kind of situation, especially a class of antibiotics that prevent the incision together, this is particularly evident in the decline, because a lot of this together with the original, this time together to do a lot for this restrictions. Hierarchical management concept I mentioned earlier, in fact, originally I was just non-restricted, restricted, restricted officers can use the above signatures are basically, but this time said no, I would add a special class of medication, that the original director sign on the line, must now be approved by the hospital management committee of antibiotics, this one actually operate in big trouble, a special class of medication, in fact, most of our foreign agents, such as our fungus medication, in practice there will be some difficulties, a little later we will see a lot of doctors now say how to do, where or not to save the patient, the actual hospital to discuss how this is to do this thing.

    We expect the strength in accordance with the Ministry of Health are now talking about the fact that their determination, we expect a variety of restrictions that a child will soon be on our direct impact, if each company there are antibiotics in hand, the first things children say one thing to do this quickly, this is a truth for us is the survival of this species limits entered into, and out of the hospital as early as possible to give up, not you, not to say that once a medication how, basically want to say again the next time. Of course, there are special circumstances that you are purchasing the so-called temporary, this one is every hospital can do, but provides more than five times the next time you have to enter, or not set up this temporary purchases, a little gap, you see this one I think children need to do early, early varieties of line must be done.

    There together with the original words related to the antibiotics, we have patents together, no problems have basically no generic drugs, in general more favorable. Relatively speaking, I think it is beneficial.

    Top three hospitals in major cities now have taken antibiotics in the management committee, they have begun to do this one thing. But Chengdu, the three general hospitals began to do this are not many children. Now look at the management of the Ministry of Health, the speed should be fast, requiring hospitals to do.

    In the hierarchical management that together, basically where specific policies which have medicinal requirements. Restricted special treatment to this level, this is a new level, this time the hospital has a great decision-making power, the advantage we are doing (in English) This is the level of division together, there are many drugs, the general limit of the special treatment can go, due to special drug approval process less complicated this together, I think (English) has a thing to do is (in English) above should also have some things to do.

    Drugs to regulate these together, in fact, different surgical scale prevention, surgery is the prevention of the finest speakers, and even that surgery should prevent surgery hours between 30 minutes of surgery, should return to this category. So that specific management measures above are some very specific requirements. This is the actual medicine the doctor together will have an impact, to be honest with little effect on clinicians because the clinical, preventive medication classes most of the prevention of drug selection is a kind of habit, habit out of medicine, To be honest the new management system basically are allowed, only possible on the original master of this operation time is not so strict, must now be serious some, I think the difference is probably in this one aspect.

    This is what the new policy together what kind of direction. We look at this policy for the entire so-called acts of our market what kind of impact, I think the biggest impact to see a doctor hands the power to imagine the future, this policy environment, a doctor will hand power to a small a small lot, especially in the drug selection of species, because you see the policy implications are basically limited variety of antibiotics, there is no relationship, and what you can influence. Rational use of drugs provides some surgery now can be used in accordance with the provisions of the original is not available, this one a great impact. Total control medication, tell the truth in each hospital had its own health insurance which, we also had to do this, the total control of impact, but should not be so great, because the doctor or the hands of the so-called flexibility. Surgical clinical pathway itself does not exist to tell the truth, medical treatment will have some impact but the impact on the basic few. The first clinical pathways, clinical pathways we have now a total of 20 in accordance with the rules of clinical disease path, and it basically does not recognize a national health insurance, most of the antibiotics used in clinical pathways, the Ministry of Health said there is no honest way to be, Basically no impact. This is from the policy level impact on the overall market analysis from several aspects.

    The clinicians point of view, the actual medical treatment options will be limited, because fewer species, the original practice of using some of the drug habit or even prefer some of the brands, there are basic, no no, the choice of special medical treatment effect will that have on. Management at different levels, the average doctor will say that I go is so original, so there is no effect. Medicine will have some impact here, actually you see such a doctor complaining of personalized treatment for different patients how to pick these things are gone. This fact, together I think there are good and bad. For us, are generally said to establish the brand concept, and establish my (English) concept, but where this policy will also affect the choice of medical drugs, which together more of our (English) challenge, how this part of the future do, how to consider medication management under the framework can then talk about our brand.

    Proportion of drug control has no effect, as has been doing, no matter what level of restrictions, had no effect.

    In fact, the total reflection surface do more to make a fuss. Practice of doctors, the patient no good. Basically good, these restrictions are, the sick dancing, more and more disease. Doctors do not think much. I say enough of how many hospitals so much? He said that in full accordance with the provisions of 35 kinds is enough, but every doctor has to understand every doctor, every person has the choice of each person. He said the antibiotics, he also agreed to the use of sucks, but the problem lie? Level is not enough doctors, not make the right judgments, and have actually called the Ministry of Health to manage not solve this fundamental problem.

    We look good, specific these effects are basically the first restriction that the so-called species together, which together tone of each hospital, all doctors we are the first execution, after the adjustment, acquire this number down to pay the difference, the latter how to do it again, have a look at the problem. The concept is so basic. Here the greatest impact on surgical prophylaxis for surgery, we say that this in itself does not require too many, with the only saying that the original from the 50 cephalosporins which can be selected from the two inside the election now, they will not feel much of a problem. Medicine greatest impact. Where is the largest? Like breathing, blood in this class sections, they are all using more high-end antibiotics, under the New Deal are essentially management, especially the strict set of procedures such as the use of drugs, will have a significant impact on them. Most medical departments to reflect the patient is not good for us so bad, in fact, is that this one thing wrong, of course, in practice, as we talk with the Department of Respiratory Medicine, Department of Hematology talk, they think this thing is not so large impact, basic antibiotics in the hospital management committee composed of, in particular, are basically the two leading sections of the people, will be a good sign to sign, should have little effect, so from this point on should be able to, but now power up close, receiving hospital, this will not be rent-seeking and out, a new round hotbed of corruption, kickbacks, said most antibiotics, and now power up close do not know which one will have to take a lot of money, most doctors would look at the limit .

    Impact on the market, the variety should be the maximum limit impact on the market. In terms of foreign species selection, selection criteria actually see behind me is the amount of the first, small manufacturers in the inside, the greatest impact on small manufacturers. Certainly increase the amount of the original hundreds, now thirty-five ten kinds of usage will increase, in general, I think it\\ s more beneficial to a number of species limits.

    Standard real impact here, one is the prevention of where you choose what you choose so little, that the original surgery that together we all use their own medication, this should also okay. In terms of medicine, but also, you walk down to see all levels of the specific drug is not significantly affected. In fact, what you see is missing this together, the whole New Deal down, I personally agree with the doctor\\ s education is most important, specific restrictions on these things I can not see this one thing and antibiotic usage can be pressed down. There are three generations of insurance, including anti-fungal that together, the market should be more smaller. From the program management process, a lot of antibiotics is the original ladder, where a lot of time into the path more willing, I think there will be some impact.

    This segment together, before the implementation of the so-called, where up second-generation with the new rules down can only use second-generation cephalosporin. The next generation of New Deal can only use it for good with a generation. This is considered a type of medication. Types of medical management at different levels with a little more, less restrictions, this special class together, because to the Board for approval, which together I think it will perform, together with this special class will perform a deeper, non-prescription signed decision will not change much, because most critically ill patients in these departments, to manage their own job is to lead, not too restrictive for them.

    Together to prevent this is will be much affected. Because most of the varieties would be affected. Basically, you see that a good market, in the end what the impact of a general hospital that you have to do this thing, cut from the original 90,120 to 90,35 how reduced, the general said the first thing to do, we There are 100 kinds, with all the weed out less, which together directly affect small and medium enterprises, our so-called small products, a similar but do little peril, because the hospital there is no room for bargaining, basic across the board, then is not a class of drugs of various types of state regulations inconsistent with the state to change over, this is the second child to do things, and the third thing is to consider the children how to regulate a specific product, and domestic and imported how do you balance the total The view will follow the basic high-level antibiotic has been used in recent years. And feedback from primary care doctors, too, which could do with our relationship the way different products, there is still some difference between the brand, this time I feel that every hospital in the so-called concept of a domestic imports of the above, there will be a consideration, then consider the price factor, this time it is difficult to consider, you have only two options for a price like this, to be honest there is no competition. We are also listed, in fact, the most important thing is that few, that is, product regulation, in the present market share, the size of the market capacity, as well as national regulations. The state has said this is a new special class of drugs, which together let me in the hospital level to address, we said yes, there are a lot of work to do.

    It looked different types together what, in this case is a special case has been how to get out. Just now we talked a lot, the Chinese market very, very good, how kind of the direction of health reform, how kind of policy, we would like to say well I see a specific policy in the short term, the market conduct of the doctors have any effect, I hope shed some light on you, our market strategy to help make the product measure, we will see that in fact the policy analysis, policy implications, I think it is necessary to support the content. Changes in the macroeconomic environment in the market for a product focus is the recent influential. Here is my contact information, we can communicate back, thank you.